NCT06753578 Effectiveness of an ACT-Based Cognitive Intervention on Quality of Life and Cognitive Function in Elderly Residents With MCI
| NCT ID | NCT06753578 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Instituto de Investigación Marqués de Valdecilla |
| Condition | Mild Cognitive Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 215 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2024-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 215 participants in total. It began in 2024-01-01 with a primary completion date of 2024-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the effects of an Acceptance and Commitment Therapy (ACT)-based cognitive intervention on Quality of Life (QOL) and cognitive function among elderly residents with Mild Cognitive Impairment (MCI) in long-term care settings. The study assesses immediate and long-term impacts on cognitive function, psychological flexibility, social engagement, and overall well-being through structured ACT-based training.
Eligibility Criteria
Inclusion Criteria: * Residents aged 65 and older diagnosed with MCI, able to provide informed consent, and residing in participating long-term care facilities. Exclusion Criteria: * Individuals with severe cognitive impairment, unstable medical conditions, or psychiatric diagnoses that would interfere with participation.
Frequently Asked Questions
Who can join the NCT06753578 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Mild Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06753578 currently recruiting?
Yes, NCT06753578 is actively recruiting participants. Visit ClinicalTrials.gov or contact Instituto de Investigación Marqués de Valdecilla to inquire about joining.
Where is the NCT06753578 trial being conducted?
This trial is being conducted at Santander, Spain.
Who is sponsoring the NCT06753578 clinical trial?
NCT06753578 is sponsored by Instituto de Investigación Marqués de Valdecilla. The trial plans to enroll 215 participants.